CN1112201C - Chinese medicine for curing hepatitis B and cirrhosis ascites - Google Patents
Chinese medicine for curing hepatitis B and cirrhosis ascites Download PDFInfo
- Publication number
- CN1112201C CN1112201C CN00123121A CN00123121A CN1112201C CN 1112201 C CN1112201 C CN 1112201C CN 00123121 A CN00123121 A CN 00123121A CN 00123121 A CN00123121 A CN 00123121A CN 1112201 C CN1112201 C CN 1112201C
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- rhizoma
- hepatitis
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a traditional Chinese medicine for curing hepatitis B and cirrhosis ascites. The traditional Chinese medicine of cornua rhinoceri pallidum, oldenlandia diffusa, alkanna tinctoria, Chinese lobelia herb, rhizoma, gecko swinhoana, bittersweet herb, patrinia scabiosaefolia link, goose's gizzard membrane, semen coicis, rhubarb, comfrey root, Chinese goldthread, giant knutweed rhizome, phellodendron bark, red peony root, parasitism, honeysuckle, semen pharbitidis, oriental waterplantain rhizome, glabrous greenbrier rhizome, fructus corni, schizandra sinensis, astragalus root, codonopsis pilosula, heterophylly falsestarwort root, artemisiae scopariae, gentian root, red sage root, cortex moutan, angelica, bupleurum root, bitter orange, green tangerine peel, akebia stem, imperatae rhizoma, chuanxiong rhizome, licorice root, radix morindae officinalis, etc. is pulverized into powder, the powder is filled into capsules, and a traditional Chinese medicine for treating chronic hepatitis B is made. The present invention can be used for treating acute hepatitis B and other diseases when the cornua rhinoceri pallidum is saved. Supplementary material is added on the basis of principle material, so the present invention can treat hepatic ascites diseases, and the curative ratio reaches more than 95%.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hepatitis B.
Background technology
Hepatitis B is China people's commonly encountered diseases, a frequently-occurring disease, it also is a kind of obstinate disease, Type B viral hepatitis harm is big, propagation is wide, development is fast, the grievous injury human beings'health, the progress of relevant diagnosis of hepatitis b aspect is very fast both at home and abroad in recent years, but the treatment aspect lacks active drug, particularly hepatitis B small three positive and the hepatitis B great three positive is the disease that heals than refractory in the hepatitis B.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of hepatitis B and cirrhotic ascites, this Chinese medicine can effect a radical cure hepatitis B diseases, instant effect, and good effect, cure rate reaches more than 95%.
The present invention treats hepatitis B great three positive Chinese medicine primary raw material medicine composition and weight proportion is:
GUANGXIJIAO 10g, Herba Hedyotidis Diffusae 50g, Radix Arnebiae (Radix Lithospermi) 50, Herba Lobeliae Chinensis 60g, Rhizoma Paridis 50g, Gekko Swinhonis 10g, Herba Solani Lyrati 20g, Herba Patriniae 50g, Endothelium corneum 40g, Semen Coicis 50g, Radix Et Rhizoma Rhei 50g, Fructus Gardeniae 50g, Rhizoma Coptidis 60g, Rhizoma Polygoni Cuspidati 50g, Radix Isatidis 100g, Cortex Phellodendri 50g, Radix Paeoniae Rubra 50g, parasitic 60g, Flos Lonicerae 40g, each 15g of black and white Semen Pharbitidis, Rhizoma Alismatis 40g, Rhizoma Smilacis Glabrae 100g, Fructus Corni 50g, Radix Schisandrae Bicoloris 40g, Radix Astragali 50g, Radix Codonopsis 40g, Radix Pseudostellariae 40g, Herba Artemisiae Scopariae 100g, north Radix Gentianae 50g, Radix Salviae Miltiorrhizae 50g, Cortex Moutan 50g, Radix Angelicae Sinensis 100g, Radix Bupleuri 50g, Fructus Aurantii 50g, Pericarpium Citri Reticulatae Viride 40g, Caulis Akebiae 60g, Rhizoma Imperatae 100g, Rhizoma Chuanxiong 50g, Radix Glycyrrhizae 50g, crust halberd 50g.
The compound method of Chinese medicine of the present invention is the above-mentioned raw materials medicine to be ground into powder, the medium capsule of packing into, the i.e. Chinese medicine of preparation cost invention treatment hepatitis B great three positive and icterohepatitis.This capsule was taken secondary in one day, a 3-5 grain.
Chinese medicine of the present invention also can be processed into decoction, dose need reduce by half, above-mentioned other 40 flavor Chinese medicine except that GUANGXIJIAO was soaked 30 minutes, put into container, adding water is as the criterion to surpass Chinese medicine 3cm, decoct 30 minutes after-filtration with slow fire, filtrate is equipped with the GUANGXIJIAO end and promptly makes the Chinese medicine that the present invention treats hepatitis B great three positive and icterohepatitis.Decoction is taken inconvenient, but curative effect is better than capsule, generally can shift to an earlier date recovery from illness in 10 days.
Chinese medicine of the present invention, GUANGXIJIAO, Herba Hedyotidis Diffusae, Herba Lobeliae Chinensis, Gekko Swinhonis, Herba Solani Lyrati, Radix Arnebiae (Radix Lithospermi), Rhizoma Smilacis Glabrae, Rhizoma Coptidis can directly kill hepatitis B virus, separate the medicine of the sick the best of hepatitis B great three positive; Herba Patriniae, Rhizoma Polygoni Cuspidati, Radix Isatidis, Cortex Phellodendri, Herba Artemisiae Scopariae, northern Radix Gentianae clearing away damp-heat jaundice eliminating gallbladder; Radix Angelicae Sinensis, Radix Paeoniae Rubra, Cortex Moutan, Radix Salviae Miltiorrhizae, Radix Bupleuri, Fructus Aurantii, Pericarpium Citri Reticulatae Viride, Caulis Akebiae, Rhizoma Imperatae, the Rhizoma Chuanxiong branch stagnant heat that purifies the blood of invigorating blood circulation, soothing liver-QI is built spleen; Endothelium corneum, Semen Coicis, Radix Et Rhizoma Rhei, Fructus Gardeniae, black and white Semen Pharbitidis, Rhizoma Alismatis, Radix Schisandrae Bicoloris blood stasis dispelling purging FU-organs, dampness removing; Fructus Corni, the Radix Astragali, Radix Codonopsis, Radix Pseudostellariae, crust halberd fill blood should kidney yin.
This Chinese medicine cures mainly that the epidemic disease poison is invaded liver, hepatic region twinge, abdominal distention, felt sick, malaise, dizziness, order are puckery, pain is itched at the canthus, insufficiency of the spleen stomach is weak, damage of kidney-YIN, strengthening vital QI to eliminate pathogenic factors, clearing away damp-heat are separated the epidemic disease poison.The most obvious to treatment hepatitis B great three positive, icterohepatitis effect.
GUANGXIJIAO in the material medicine of the present invention is removed, and other 40 flavor Chinese medicine is ground into powder, can treat hepatitis B small three positive and hepatitis B virus and carry disease.
In material medicine, add other auxiliary Chinese medicine Carapax Eretmochelydis 40g, Catharsii molossi 20g, Hirudo 10g, Eupolyphaga Seu Steleophaga 40g, Carapax Trionycis 60g, Radix Notoginseng 30g, Semen Persicae 50g, Flos Carthami 50g, Caulis Spatholobi 60g, Rhizoma Curcumae 50g, Fructus Toosendan 50g, Eupolyphaga seu steleophaga 20g in the present invention, be ground into powder, incapsulate, can be used for treating cirrhotic ascites.
Described Chinese medicine, GUANGXIJIAO, Carapax Eretmochelydis, Herba Hedyotidis Diffusae, Rhizoma Smilacis Glabrae directly kill hepatitis B virus, and it is the strongest that these several medicines are separated hepatitis B virus, Hirudo, Eupolyphaga Seu Steleophaga, Semen Persicae, Flos Carthami, Eupolyphaga seu steleophaga, the Rhizoma Curcumae strongly fragrant liver spleen that contracts that looses of invigorating blood circulation; Radix Angelicae Sinensis, Radix Paeoniae Rubra, Radix Notoginseng, Cortex Moutan, Radix Salviae Miltiorrhizae, Caulis Akebiae, Rhizoma Imperatae cooling blood for hemostasis, Radix Bupleuri, Fructus Aurantii, Fructus Toosendan, Cortex Phellodendri liver-smoothing, qi-regulating; The Radix Astragali, Radix Codonopsis, Radix Pseudostellariae, Caulis Spatholobi, the empty suitable kidney of crust halberd QI invigorating; Rhizoma Alismatis, black and white Semen Pharbitidis, Radix Et Rhizoma Rhei Tongli rush down damp and hot, and this hepatitis B sclerosis ascites makes the gas promoting the circulation of blood smooth, and stasis of blood water disappears without diuretic, and water reaches rehabilitation efficacy from disappearing.
This Chinese medicine cures mainly hbv-liver cirrhosis ascites, hepatosplenomegaly, obstinate, expansion tooth epistaxis, body of the tongue yellow fur, thick contrary or no fur, ecchymosis, big dry stool are arranged or half congealedly rush down, oliguria is puckery, hepatic region twinge, complexion are gloomy, estimate good and evil, the blood stasis dispelling circulation of qi promoting diseases such as tympanites that disappear.
The specific embodiment
Be to use the clinical practice of treatment by Chinese herbs hepatitis B patient of the present invention below.
Hepatitis B kind number cure to take a turn for the better invalid effective percentage course of treatment (my god)
Hepatic ascites 156 141 11 4 97% 46-91
Hepatitis B great three positive 167 152 96 96% 60-96
Hepatitis B small three positive 278 261 13 4 99% 30-66
Hepatitis B for the poison 251 248 12 99% 30-45 from last table, hepatitis B for the poison and the hepatitis B small three positive state of an illness than the lighter, take Chinese medicinal capsule of the present invention, can transfer feminine gender in general 30 days, heavy person also can fully recover about 90 days, but hepatitis B is transferred to hepatocarcinoma person, and is invalid.
Claims (3)
1, a kind of Chinese medicine for the treatment of hepatitis B, it is characterized in that: it is made up of following materials of weight proportions medicine basically, Herba Hedyotidis Diffusae 50g, Radix Arnebiae (Radix Lithospermi) 50g, Herba Lobeliae Chinensis 60g, Rhizoma Paridis 50g, Gekko Swinhonis 10g, Herba Solani Lyrati 20g, Herba Patriniae 50g, Endothelium corneum 40g, Semen Coicis 50g, Radix Et Rhizoma Rhei 50g, Fructus Gardeniae 50g, Rhizoma Coptidis 60g, Rhizoma Polygoni Cuspidati 50g, Radix Isatidis 100g, Cortex Phellodendri 50g, Radix Paeoniae Rubra 50g, parasitic 60g, Flos Lonicerae 40g, each 15g of black and white Semen Pharbitidis, Rhizoma Alismatis 40g, Rhizoma Smilacis Glabrae 100g, Fructus Corni 50g, Radix Schisandrae Bicoloris 40, Radix Astragali 50g, Radix Codonopsis 40g, Radix Pseudostellariae 40g, Herba Artemisiae Scopariae 100g, north Radix Gentianae 50g, Radix Salviae Miltiorrhizae 50g, Cortex Moutan 50g, Radix Angelicae Sinensis 100g, Radix Bupleuri 50g, Fructus Aurantii 50g, Pericarpium Citri Reticulatae Viride 40g, Caulis Akebiae 60g, Rhizoma Imperatae 100g, Rhizoma Chuanxiong 50g, Radix Glycyrrhizae 50g, crust halberd 50g; The compound method of Chinese medicine of the present invention is, above-mentioned Chinese medicine is ground into powder, incapsulates the Chinese medicine of i.e. preparation cost invention treatment hepatitis B great three positive and icterohepatitis.
2, a kind of Chinese medicine for the treatment of hepatitis B according to claim 1, it is characterized in that: material medicine also can add GUANGXIJIAO 10g.
3, a kind of Chinese medicine for the treatment of hepatitis B according to claim 1, it is characterized in that: material medicine also can add following medicine: Carapax Eretmochelydis 40g, Catharsii molossi 20g, Hirudo 10g, Eupolyphaga Seu Steleophaga 40g, Carapax Trionycis 60g, Radix Notoginseng 30g, Semen Persicae 50g, Flos Carthami 50g, Caulis Spatholobi 60g, Rhizoma Curcumae 50g, Fructus Toosendan 50g, Eupolyphaga seu steleophaga 20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00123121A CN1112201C (en) | 2000-10-21 | 2000-10-21 | Chinese medicine for curing hepatitis B and cirrhosis ascites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00123121A CN1112201C (en) | 2000-10-21 | 2000-10-21 | Chinese medicine for curing hepatitis B and cirrhosis ascites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1304744A CN1304744A (en) | 2001-07-25 |
| CN1112201C true CN1112201C (en) | 2003-06-25 |
Family
ID=4589598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00123121A Expired - Fee Related CN1112201C (en) | 2000-10-21 | 2000-10-21 | Chinese medicine for curing hepatitis B and cirrhosis ascites |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1112201C (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299727C (en) * | 2004-05-25 | 2007-02-14 | 李春光 | Chinese medicinal preparation for hepatitis and its preparing method (2) |
| CN100346800C (en) * | 2004-11-08 | 2007-11-07 | 北京万邦医药投资有限公司 | Chinese medicine composition for preventing and treating hepatitis |
| CN101879242B (en) * | 2009-05-04 | 2011-11-16 | 上海中医药大学附属曙光医院 | Traditional Chinese medicine composition for treating chronic virus b hepatitis through immunity regulation and control |
| CN101810826B (en) * | 2010-04-13 | 2012-01-11 | 邵梦扬 | Chinese medicament for treating liver cancer |
| CN102302544B (en) * | 2011-08-25 | 2013-04-10 | 上海中医药大学 | Chinese medicinal composition for preventing and treating hepatic fibrosis |
| CN102512631B (en) * | 2011-12-23 | 2013-06-26 | 林静 | Chinese medicinal composition for treating jaundice |
| CN103272189B (en) * | 2013-06-19 | 2014-06-25 | 胡立萍 | Medicine for curing gallstones |
| CN104367933A (en) * | 2013-08-13 | 2015-02-25 | 陈立云 | Medicinal powder for treating liver cirrhosis and liver ascites |
| CN105169221A (en) * | 2015-07-29 | 2015-12-23 | 陈忠田 | Traditional Chinese medicine composition for treating ascites due to cirrhosis |
| CN105477542A (en) * | 2015-12-15 | 2016-04-13 | 郭璐 | Traditional Chinese medicine composition for treating cirrhosis |
| CN105381410A (en) * | 2015-12-18 | 2016-03-09 | 徐静 | Traditional Chinese medicinal preparation for treating hepatitis |
| CN105748847A (en) * | 2016-05-10 | 2016-07-13 | 张维霞 | Traditional Chinese medicine preparation for treating ascites due to cirrhosis and preparation method of traditional Chinese medicine preparation |
| CN106177796A (en) * | 2016-08-30 | 2016-12-07 | 刘仪龙 | For treating the Chinese medicine composition of hepatitis B |
| CN107715059A (en) * | 2017-10-31 | 2018-02-23 | 赵利红 | A kind of Chinese medicinal pill for liver class disease and preparation method thereof |
| CN110960666A (en) * | 2019-12-31 | 2020-04-07 | 谭帮勇 | Traditional Chinese medicine compound mixture for treating liver cirrhosis and preparation method thereof |
| CN114042137A (en) * | 2021-12-11 | 2022-02-15 | 宁凤霞颐和堂咨询服务(珠海市)有限公司 | Traditional Chinese medicine formula for treating liver ascites |
-
2000
- 2000-10-21 CN CN00123121A patent/CN1112201C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1304744A (en) | 2001-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101637585B (en) | Chinese herbal preparation for treating posirasis and preparation method thereof | |
| CN1112201C (en) | Chinese medicine for curing hepatitis B and cirrhosis ascites | |
| CN103463528B (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN1081067C (en) | Chinese medicine prescription for curing hepatitis, cholangitis, pancreatitis and cirrhosis | |
| CN1100651A (en) | Chinese herbal prepn. for curing chronic gastroenteritis and peptic gastric ulcer | |
| CN1151806C (en) | Capsule for curing cholecystitis | |
| CN102000301A (en) | Traditional Chinese medicine composite for treating mammitis and lobular hyperplasia of mammary gland and preparation method thereof | |
| CN101708297A (en) | Medicament for treating gout disease | |
| CN102048961A (en) | Traditional Chinese medicine preparation for treating hypertension | |
| CN103041200B (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
| CN101940759B (en) | Chinese medicinal composition for treating liver diseases and preparation method and application thereof | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN1218706C (en) | Hepatitis B treaitng pill | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN101642532A (en) | Traditional Chinese medicine composition for treating apoplexy and preparation method thereof | |
| CN101264218A (en) | Medicaments assembly for clearing heat and removing dampness, smoothing liver and invigorating spleen and preparation thereof | |
| CN101085088A (en) | Traditional Chinese medicine formula for treating prostatic hyperplasia | |
| CN1298724A (en) | Medicine for treating immunodefiiciency disease | |
| CN1277575C (en) | Medicine for treating hyperosteogeny and its preparation method | |
| CN103948875A (en) | Medicine for treating hepatitis B and preparation method thereof | |
| CN102580031B (en) | External Chinese medicament for treating chilblain and preparation method thereof | |
| CN1562229A (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN105833152A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN104547752A (en) | Traditional Chinese medicine composition for treatment of dampness-heat in lower jiao | |
| CN104688916A (en) | TCM (Traditional Chinese Medicine) composition for treating psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |